BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7946443)

  • 1. Addition of IFN-alpha to treatment of malignant brain tumors.
    Jereb B; Petric-Grabnar G; Klun B; Lamovec J; Skrbec M; Soos E
    Acta Oncol; 1994; 33(6):651-4. PubMed ID: 7946443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor application of human leukocyte interferon-alpha in patients with malignant brain tumors.
    Jereb B; Petric J; Lamovec J; Skrbec M; Soss E
    Am J Clin Oncol; 1989 Feb; 12(1):1-7. PubMed ID: 2536212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant astrocytic gliomas in children.
    Marchese MJ; Chang CH
    Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
    Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
    Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
    Buckner JC; Brown LD; Kugler JW; Cascino TL; Krook JE; Mailliard JA; Kardinal CG; Tschetter LK; O'Fallon JR; Scheithauer BW
    J Neurosurg; 1995 Mar; 82(3):430-5. PubMed ID: 7861221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.
    Wallner KE; Galicich JH; Krol G; Arbit E; Malkin MG
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1405-9. PubMed ID: 2542195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas.
    Fine HA; Wen PY; Robertson M; O'Neill A; Kowal J; Loeffler JS; Black PM
    Clin Cancer Res; 1997 Mar; 3(3):381-7. PubMed ID: 9815695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
    Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermoradiotherapy of recurrent malignant brain tumors.
    Sneed PK; Gutin PH; Stauffer PR; Phillips TL; Prados MD; Weaver KA; Suen S; Lamb SA; Ham B; Ahn DK
    Int J Radiat Oncol Biol Phys; 1992; 23(4):853-61. PubMed ID: 1319981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
    Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
    Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermia treatment for malignant brain tumors: nursing management during therapy.
    Edwards DK; Stupperich TK; Welsh DM
    J Neurosci Nurs; 1991 Feb; 23(1):34-8. PubMed ID: 1849946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current knowledge and treatment strategies for grade II gliomas.
    Narita Y
    Neurol Med Chir (Tokyo); 2013; 53(7):429-37. PubMed ID: 23883553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade glioma in children and adolescents: a single-center experience.
    Yazici G; Zorlu F; Cengiz M; Ozyigit G; Eren G; YĆ¼ce D; Varan A; Akyuz C; Akalan N; Gurkaynak M
    Childs Nerv Syst; 2016 Feb; 32(2):291-7. PubMed ID: 26679932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retreatment of intracranial gliomas.
    Landy HJ; Feun L; Schwade JG; Snodgrass S; Lu Y; Gutman F
    South Med J; 1994 Feb; 87(2):211-4. PubMed ID: 8115886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined intra-arterial chemotherapy and irradiation of malignant gliomas.
    Watne K; Nome O; Hager B; Hirschberg H
    Acta Oncol; 1991; 30(7):835-41. PubMed ID: 1662522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant brain tumors with focused ultrasound hyperthermia and radiation: results of a phase I trial.
    Guthkelch AN; Carter LP; Cassady JR; Hynynen KH; Iacono RP; Johnson PC; Obbens EA; Roemer RB; Seeger JF; Shimm DS
    J Neurooncol; 1991 Jun; 10(3):271-84. PubMed ID: 1654406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new treatment for high grade gliomas of the brain.
    Brady LW
    Bull Mem Acad R Med Belg; 1998; 153(5-6):255-61; discussion 261-2. PubMed ID: 9988932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival in malignant glioma. Prognostic factors.
    Phuphanich S; Ferrall S; Greenberg H
    J Fla Med Assoc; 1993 Mar; 80(3):181-4. PubMed ID: 8387566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.